These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36091686)

  • 21. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
    Chai L; Cai K; Wang K; Luo Q
    J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the Haas and the Oxford classifications for prediction of renal outcome in patients with IgA nephropathy.
    Park KS; Han SH; Kie JH; Nam KH; Lee MJ; Lim BJ; Kwon YE; Kim YL; An SY; Kim CH; Doh FM; Koo HM; Oh HJ; Kang SW; Choi KH; Jeong HJ; Yoo TH
    Hum Pathol; 2014 Feb; 45(2):236-43. PubMed ID: 24439222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictability of the Oxford classification of IgA nephropathy in Henoch-Schonlein purpura nephritis.
    Luo X; Tan J; Wan D; Chen J; Hu Y
    Int Urol Nephrol; 2022 Jan; 54(1):99-109. PubMed ID: 33905044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
    Trimarchi H; Barratt J; Cattran DC; Cook HT; Coppo R; Haas M; Liu ZH; Roberts IS; Yuzawa Y; Zhang H; Feehally J; ;
    Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).
    Edström Halling S; Söderberg MP; Berg UB
    Nephrol Dial Transplant; 2012 Feb; 27(2):715-22. PubMed ID: 21750154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the Oxford classification of IgA nephropathy for pediatric patients from China.
    Le W; Zeng CH; Liu Z; Liu D; Yang Q; Lin RX; Xia ZK; Fan ZM; Zhu G; Wu Y; Xu H; Zhai Y; Ding Y; Yang X; Liang S; Chen H; Xu F; Huang Q; Shen H; Wang J; Fogo AB; Liu ZH
    BMC Nephrol; 2012 Nov; 13():158. PubMed ID: 23181565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy.
    Yoon CY; Chang TI; Kang EW; Lim BJ; Kie JH; Kee YK; Kim H; Park S; Yun HR; Jung SY; Jhee JH; Kwon YE; Oh HJ; Park JT; Yoo TH; Kang SW; Jeong HJ; Han SH
    Ann Med; 2017 May; 49(3):217-229. PubMed ID: 27764976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Updated Oxford classification and the international study of kidney disease in children classification: application in predicting outcome of Henoch-Schönlein purpura nephritis.
    Huang X; Ma L; Ren P; Wang H; Chen L; Han H; Chen J; Han F
    Diagn Pathol; 2019 May; 14(1):40. PubMed ID: 31077245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis.
    Casal Moura M; Fervenza FC; Specks U; Sethi S
    Nephrol Dial Transplant; 2022 Aug; 37(9):1710-1721. PubMed ID: 34436585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microangiopathic Lesions in IgA Nephropathy: A Cohort Study.
    Cai Q; Shi S; Wang S; Ren Y; Hou W; Liu L; Lv J; Haas M; Zhang H
    Am J Kidney Dis; 2019 Nov; 74(5):629-639. PubMed ID: 31103332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.
    Coppo R; Troyanov S; Bellur S; Cattran D; Cook HT; Feehally J; Roberts IS; Morando L; Camilla R; Tesar V; Lunberg S; Gesualdo L; Emma F; Rollino C; Amore A; Praga M; Feriozzi S; Segoloni G; Pani A; Cancarini G; Durlik M; Moggia E; Mazzucco G; Giannakakis C; Honsova E; Sundelin BB; Di Palma AM; Ferrario F; Gutierrez E; Asunis AM; Barratt J; Tardanico R; Perkowska-Ptasinska A;
    Kidney Int; 2014 Oct; 86(4):828-36. PubMed ID: 24694989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.
    Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Tsuchimoto A; Noguchi H; Hirakata H; Tsuruya K; Kitazono T
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2082-90. PubMed ID: 24178970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproducibility for pathological prognostic parameters of the Oxford classification of IgA nephropathy: a Japanese cohort study of the Ministry of Health, Labor and Welfare.
    Hisano S; Joh K; Katafuchi R; Shimizu A; Hashiguchi N; Kawamura T; Matsuo S;
    Clin Exp Nephrol; 2017 Feb; 21(1):92-96. PubMed ID: 27011013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between complement deposition and the Oxford classification score and their combined effects on renal outcome in immunoglobulin A nephropathy.
    Park S; Kim HW; Park JT; Chang TI; Kang EW; Ryu DR; Yoo TH; Chin HJ; Jeong HJ; Kang SW; Lim BJ; Han SH
    Nephrol Dial Transplant; 2020 Dec; 35(12):2103-2137. PubMed ID: 31377783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The new Oxford Clinico-Pathological Classification of IgA nephropathy.
    Coppo R; Cattran D; Roberts Ian SD; Troyanov S; Camilla R; Cook T; Feehally J
    Prilozi; 2010; 31(1):241-8. PubMed ID: 20693944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
    Segarra-Medrano A; Carnicer-Caceres C; Valtierra-Carmeno N; Agraz-Pamplona I; Ramos-Terrades N; Jatem Escalante E; Ostos-Roldan E
    Nefrologia; 2017; 37(5):531-538. PubMed ID: 28946966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilizing the MEST score for prognostic staging in IgA nephropathy.
    Haaskjold YL; Bjørneklett R; Bostad L; Bostad LS; Lura NG; Knoop T
    BMC Nephrol; 2022 Jan; 23(1):26. PubMed ID: 35016634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study.
    Kataoka H; Ohara M; Suzuki T; Inoue T; Akanuma T; Kawachi K; Manabe S; Ushio Y; Kawasoe K; Akihisa T; Sato M; Iwasa N; Sawara Y; Honda K; Mochizuki T; Tsuchiya K; Nitta K
    PLoS One; 2020; 15(5):e0232885. PubMed ID: 32379841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.